Portfolio (Quarterly)
Guide ↗
Rosalind Advisors, Inc.
· CIK 0001622627| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DCTH | DELCATH SYSTEMS, INC. | Healthcare | 3,300,389.0 | $33.0M | 11.60% | NEW | — | $10.00 | +9.7% |
| 2 | SVRA | SAVARA INC | Healthcare | 3,403,721.0 | $20.5M | 7.21% | NEW | — | $6.03 | -16.6% |
| 3 | FENC | FENNEC PHARMACEUTICALS INC | Healthcare | 2,613,508.0 | $20.1M | 7.07% | NEW | — | $7.70 | +28.1% |
| 4 | XERS | XERIS BIOPHARMA HOLDGS INC | Healthcare | 2,111,700.0 | $16.6M | 5.83% | NEW | — | $7.85 | -21.3% |
| 5 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 450,000.0 | $14.0M | 4.92% | NEW | — | $31.12 | -44.5% |
| 6 | — | MEDIWOUND LTD | — | 749,054.0 | $13.8M | 4.86% | NEW | — | $18.46 | — |
| 7 | — | VERASTEM INC | — | 1,788,475.0 | $13.8M | 4.85% | NEW | — | $7.72 | — |
| 8 | REPL | REPLIMUNE GROUP INC | Healthcare | 1,410,497.0 | $13.7M | 4.82% | NEW | — | $9.72 | -51.9% |
| 9 | ATYR | ASTRIA THERAPEUTICS INC | Healthcare | 1,039,080.0 | $13.6M | 4.78% | NEW | — | $13.09 | -96.2% |
| 10 | HELP | CYBIN INC | Healthcare | 1,657,540.0 | $13.6M | 4.76% | NEW | — | $8.18 | -45.6% |
| 11 | EYPT | EYEPOINT PHARMACEUTICALS INC | Healthcare | 690,000.0 | $12.6M | 4.43% | NEW | — | $18.27 | -29.8% |
| 12 | CGON | CG ONCOLOGY INC | Healthcare | 300,000.0 | $12.5M | 4.38% | NEW | — | $41.52 | +48.6% |
| 13 | CYTK | CYTOKINETICS INC | Healthcare | 195,045.0 | $12.4M | 4.36% | NEW | — | $63.54 | +19.4% |
| 14 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 2,605,920.0 | $10.4M | 3.66% | NEW | — | $4.00 | +1.6% |
| 15 | — | MIND MEDICINE MINDMED INC | — | 750,000.0 | $10.0M | 3.53% | NEW | — | $13.39 | — |
| 16 | PROF | PROFOUND MEDICAL CORP | Healthcare | 1,068,955.0 | $8.4M | 2.96% | NEW | — | $7.87 | -12.8% |
| 17 | — | INSPIREMD INC | — | 3,905,743.0 | $7.0M | 2.44% | NEW | — | $1.78 | — |
| 18 | OCUL | Ocular Therapeutix, Inc | Healthcare | 400,000.0 | $4.9M | 1.71% | NEW | — | $12.14 | -32.6% |
| 19 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 215,871.0 | $4.3M | 1.53% | NEW | — | $20.12 | +37.6% |
| 20 | — | TALPHERA INC | — | 3,579,273.0 | $4.1M | 1.43% | NEW | — | $1.14 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%